Diabetic Gastroparesis Drugs Market Insights, Global Outlook and Forecast 2022-2028
Diabetic Gastroparesis Drugs Market Insights, Global Outlook and Forecast 2022-2028
The Diabetic Gastroparesis Drugs Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
The latest research study released by Market IntelliX evaluates market size and forecasts of Diabetic Gastroparesis Drugs in Global, including the following market information:
Global Diabetic Gastroparesis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Gastroparesis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prokinetic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Diabetic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Diabetic Gastroparesis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Type, 2021 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Diabetic Gastroparesis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Diabetic Gastroparesis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Gastroparesis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Gastroparesis Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Diabetic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Gastroparesis Drugs Overall Market Size
2.1 Global Diabetic Gastroparesis Drugs Market Size: 2021 VS 2028
2.2 Global Diabetic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetic Gastroparesis Drugs Players in Global Market
3.2 Top Global Diabetic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Diabetic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Gastroparesis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Diabetic Gastroparesis Drugs Market Size Markets, 2021 & 2028
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetic Gastroparesis Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Diabetic Gastroparesis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.3.2 US Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.3.3 Canada Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.3.4 Mexico Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.4.2 Germany Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.3 France Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.4 U.K. Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.5 Italy Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.6 Russia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.4.8 Benelux Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.5.2 China Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.3 Japan Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.4 South Korea Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.5.6 India Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.6.2 Brazil Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.6.3 Argentina Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, 2017-2028
6.7.2 Turkey Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.3 Israel Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetic Gastroparesis Drugs Market Size, 2017-2028
6.7.5 UAE Diabetic Gastroparesis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Diabetic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.1.5 Sumitomo Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diabetic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Diabetic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Diabetic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Diabetic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.7.5 Kyowa Kirin Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Diabetic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.8.5 Hanmi Pharm Key News
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Corporate Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2017-2022)
7.9.5 Ani Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Diabetic Gastroparesis Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|